Impact of skin capsular distance on the performance of controlled attenuation parameter in patients with chronic liver disease-Reference-Cited by-同舟云学术

Impact of skin capsular distance on the performance of controlled attenuation parameter in patients with chronic liver disease

Published:2015-03-06 Issue:11 Volume:35 Page:2392-2400
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver Int

Author:

Shen Feng¹,Zheng Rui‐Dan²,Shi Jun‐Ping³,Mi Yu‐Qiang⁴,Chen Guo‐Feng⁵,Hu Xiqi⁶,Liu Yong‐Gang⁴,Wang Xiao‐Ying⁷,Pan Qin¹,Chen Guang‐Yu¹,Chen Jian‐Neng²,Xu Liang⁴,Zhang Rui‐Nan¹,Xu Lei‐Ming¹,Fan Jian‐Gao¹

Affiliation:

1. Department of Gastroenterology Xinhua Hospital Shanghai Jiaotong University School of Medicine Shanghai China

2. Research and Therapy Centre for Liver Disease Zhengxing Hospital Zhangzhou China

3. Department of Liver Diseases The Affiliated Hospital of Hangzhou Normal University Hangzhou China

4. Research Institute of Liver Diseases Tianjin Second People's Hospital Tianjin China

5. Centre for Liver Fibrosis Treatment Unit 302 Military Hospital Beijing China

6. Department of Pathology Shanghai Medical College of Fudan University Shanghai China

7. Department of Pathology Xinhua Hospital Shanghai Jiaotong University School of Medicine Shanghai China

Funder

The National Key Basic Research Project

Chinese Foundation for Hepatitis Prevention and Control - ‘WANG Bao-En’ Liver Fibrosis Research Fund

‘Tian-qing-gan-bing’ Research Fund

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/liv.12809

Reference27 articles.

1. Diagnostic accuracy of FibroScan and comparison to liver fibrosis biomarkers in chronic viral hepatitis: A multicenter prospective study (the FIBROSTIC study)

2. Factors associated with unreliable liver stiffness measurement and its failure with transient elastography in the Chinese population

3. Feasibility and diagnostic performance of the FibroScan XL probe for liver stiffness measurement in overweight and obese patients

4. Feasibility of liver transient elastography with FibroScan® using a new probe for obese patients

5. Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multiparametric Ultrasound for Chronic Liver Disease;Radiologic Clinics of North America;2024-08

2. Diagnostic performance of quantitative ultrasonography for hepatic steatosis in a health screening program: a prospective single-center study;Ultrasonography;2024-07-01

3. Velacur ACE outperforms FibroScan CAP for diagnosis of MASLD;Hepatology Communications;2024-03-22

4. Recent advances in noninvasive assessment of liver steatosis;Polish Archives of Internal Medicine;2024-03-18

5. Non-invasive diagnosis of non-alcoholic fatty liver disease: Current status and future perspective;Heliyon;2024-03